Lloyd et al. [20] showed that peroxisomal enzyme, α-methylacyl-CoA racemase (AMACR), which enhances the transformation of branched chain fatty acids to a form suitable for β-oxidation, were highly overexpressed in prostate cancer compared with normal prostate. The gene discussed is AMACR; the disease is prostate carcinoma.